Matthew Moyer

Professor Matthew Moyer is affiliated with Penn State University, specializing in the Department of Medicine Division of Gastroenterology and Hepatology. His primary research areas include interventional endoscopy, cancerous/pre-cancerous gastrointestinal conditions, and endoscopic technology innovation.

• Gastroenterology
• Medical Device Development
• Pancreatic Cancer
• Inflammatory Bowel Disease (IBD)
• Endoscopic Surgery

Dr. Moyer leads the NIH-funded CHARM II trial for EUS-guided ablation of pancreatic cysts and co-develops the Chimera Project (radiofrequency ablation + radiation) with Penn State Bioengineering. His work spans Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), and NOTES techniques.

Recent publications highlight Randomized Trials (e.g., cold snare EMR) and Multicenter Studies (e.g., helix tacking systems). Key themes: gastrointestinal cancer prevention, bleeding hemostasis, and IBD lesion management.

Scientific recognition includes:

• Fellow, American Society for Gastrointestinal Endoscopy (FASGE)

Collaborations span institutions in the U.S. and Sydney Australia (IDE Inc.), with contributions to UN Sustainable Development Goals (SDGs) in healthcare innovation and cancer therapy.